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ABSTRACT 
 
Candace R. Myers 
KINETIC ANALYSIS OF PRIMATE AND ANCESTRAL                                    
ALCOHOL DEHYDROGENASES 
 
 Seven human alcohol dehydrogenase genes (which encode the primary enzymes 
involved in alcohol metabolism) are grouped into classes based on function and sequence 
identity.  While the Class I ADH isoenzymes contribute significantly to ethanol 
metabolism in the liver, Class IV ADH isoenzymes are involved in the first-pass 
metabolism of ethanol. 
 It has been suggested that the ability to efficiently oxidize ethanol occurred late in 
primate evolution.  Kinetic data obtained from the Class I ADH isoenzymes of marmoset 
and brown lemur, in addition to data from resurrected ancestral human Class IV ADH 
isoenzymes, supports this proposal—suggesting that two major events which occurred 
during primate evolution resulted in major adaptations toward ethanol metabolism. 
 First, while human Class IV ADH first appeared 520 million years ago, a major 
adaptation to ethanol occurred very recently (approximately 15 million years ago); which 
was caused by a single amino acid change (A294V).  This change increases the catalytic 
efficiency of the human Class IV enzymes toward ethanol by over 79-fold. Secondly, the 
Class I ADH form developed 80 million years ago—when angiosperms first began to 
produce fleshy fruits whose sugars are fermented to ethanol by yeasts.  This was followed 
by the duplication and divergence of distinct Class I ADH isoforms—which occurred 
vi 
 
during mammalian radiation.  This duplication event was followed by a second 
duplication/divergence event which occurred around or just before the emergence of 
prosimians (some 40 million years ago).  We examined the multiple Class I isoforms 
from species with distinct dietary preferences (lemur and marmoset) in an effort to 
correlate diets rich in fermentable fruits with increased catalytic capacity toward ethanol 
oxidation.  Our kinetic data support this hypothesis in that the species with a high content 
of fermentable fruit in its diet possess greater catalytic capacity toward ethanol. 
  
Thomas D. Hurley, Ph.D., Chair 
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I. INTRODUCTION  
     1. Alcohol Metabolism 
Ingested ethanol and intestinal ethanol of bacterial origin (from H. pylori) are 
absorbed through the digestive tract into the hepatic portal vessel—which leads to the 
liver (Crow & Hardman 1989).  After passing through the liver, the major organ 
responsible for alcohol metabolism, ethanol enters the systemic circulation (Lands 1998).  
Any ethanol metabolized during this initial pass through the stomach, intestinal tract and 
liver before entering the systemic circulation is referred to as “first-pass metabolism” 
(Hurley et al. 2002). 
There are three separate pathways that exist in mammalian cells for the 
metabolism of alcohol: (1) the two-enzyme pathway of cytosolic alcohol dehydrogenase 
(ADH) and mitochondrial aldehyde dehydrogenase (Shahin et al. 1992), (2) the MEOS—
or microsomal ethanol-oxidizing system containing cytochrome P450 IIE1, and (3) 
catalase.  The ADH-ALDH system is the primary pathway for alcohol metabolism, while 
the other pathways contribute significantly only under limited conditions such as chronic 
alcohol ingestion (Lands 1998; Lieber 1991; Inatomi et al. 1989). 
Two distinct steps are involved in the oxidation of ethanol through the ADH-
ALDH metabolic pathway.  First, ADH isoenzymes catalyze the reversible oxidation of 
ethanol to acetaldehyde—which is then further oxidized to acetic acid by ALDH 
isoenzymes in the second, irreversible step.  The oxidized form of nicotinamide adenine 
dinucleotide (NAD+) serves as the coenzyme and electron acceptor in both steps of the 
ADH-ALDH pathway.  The oxidation of ethanol to acetaldehyde by ADH is considered 
the rate-limiting step, where the equilibrium of this reaction favors the reduction of 
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acetaldehyde to ethanol at pH 7.0; although the reoxidation of NADH to NAD+ can be 
rate-limiting under some situations (Crabb et al. 1983; Blacklin 1958).  Alcohol 
dehydrogenases are the key enzymes in alcohol metabolism and make up 3% of liver 
soluble proteins (Edenberg & Bosron 1997).  Essentially, ethanol oxidation is driven in 
the cell by maintaining a low ratio of products to reactants in the cytosol: the low 
concentration of acetaldehyde versus ethanol is maintained by the highly efficient 
oxidation of acetaldehyde, while NADH is re-oxidized to NAD+ via the electron transport 
system in the mitochondria (Crow & Hardman 1989).  Acetic acid, which is the final 
oxidized product, can then be further harvested for energy in mitochondria via the Krebs 
cycle or used for biosynthesis (Moran et al. 1994). 
     2. Alcohol Dehydrogenase  
  Alcohol dehydrogenases, encoded by the ADH gene family, are enzymes that 
metabolize various substrates: including ethanol, retinol, other aliphatic alcohols, 
hydroxysteroids, and lipid peroxidation products (Duester et al. 1999).  ADH isoenzymes 
exist in four biological kingdoms: bacteria, yeast, plants, and animals (Branden et al. 
1975).  Human ADH isoenzymes are zinc-containing dimers consisting of two 40-kD 
subunits [Figure 1].  Each subunit, containing a structural zinc ion and a catalytic zinc 
ion, is folded into two domains: a coenzyme-binding domain and a catalytic domain.  
These domains are separated by a cleft containing a deep pocket—which accommodates 
the substrate and the nicotinamide moiety of the coenzyme.  Homologous interactions 
between the coenzyme binding domains of each subunit link the dimers together [Figure 
1] (Eklund et al. 1976). 
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 Seven ADH genes have been identified in humans—ADH1A, ADH1B, ADH1C, 
ADH4, ADH5, ADH7, and ADH6 (Hurley et al. 2002).  This seven-gene cluster is found 
on chromosome four in humans (Edenberg 2000).  All seven genes are arranges in a 
head-to-tail array in the order ADH7, ADH1C, ADH1B, ADH1A, ADH6, ADH4, ADH5.  
While individual genes range between 14 kilo bases (kb) and 23 kb, the spacing between 
them ranges from 15 kb (between Class I genes) to about 60 kb (flanking the Class I 
genes).  The entire set of seven genes spans 365 kb (Edenberg & Bosron 1997).    
ADH isoenzymes are further classified based on function and sequence identity 
(Duester et al. 1999; Edenberg 2000).  There is currently some disagreement amongst 
investigators and the Human Genome Organization (HUGO) concerning gene 
nomenclature assignments.  This thesis will utilize the HUGO assignments.  However, 
the current literature can be confusing depending on which nomenclature is utilized (for 
review see (Duester et al. 1999; Hurley et al. 2002)).  In humans, the Class I isoenzymes 
are encoded by genes ADH1A, ADH1B, and ADH1C—which yield the protein products 
α, β, and γ, respectively.  Polymorphisms occur at the ADH1B and ADH1C loci with 
different distributions amongst racial populations, giving rise to the ADH1B*1, 
ADH1B*2, and ADH1B*3 alleles and the ADH1C*1 and ADH1C*2 alleles (Hurley et al. 
2002).  The Class I enzymes and their polymeric variants can form both homo- and 
heterodimers (Edenberg & Bosron 1997).  Class II, encoded by human ADH4, yields the 
protein product π; Class III, encoded by human ADH5, yields χ; and Class IV, encoded 
by human ADH7 yields σ (Duester et al. 1999).  The Class V isoenzyme, human ADH6 
has only been identified at the gene and transcriptional level—and its function remains 
unknown (Hoog & Ostberg 2011). 
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Only Class I and Class II isoenzymes contribute significantly to ethanol 
metabolism in the liver; where Class I isoenzymes account for approximately 70% of the 
total ethanol oxidizing activity at 22 mM ethanol and Class II isoenzyme accounts for 
29% of ethanol oxidation at this concentration (Hurley et al. 2002).  Although most 
ingested ethanol is metabolized by the liver, a small fraction is metabolized prior to 
ethanol’s entry into systemic circulation—referred to as first pass metabolism.  This 
includes the initial pass through the liver en route to the systemic circulation and the 
epithelial tissues lining the stomach, which contains high levels of the Class IV ADH 
(Hurley et al. 2002).   
All three Class I ADHs are expressed in the adult liver; however, the α subunit is 
expressed first during development, the β subunit is expressed by mid-gestation, and the γ 
subunit is expressed some months after birth (Smith et al. 1971; Smith et al. 1972).  Class 
I ADHs are also highly expressed in adrenal glands, and at lower levels in kidney, lung, 
skin, and other tissues (Edenberg 2000).   
In general, the basic functional characteristics of Class I ADH isoenzymes are a 
low Km for ethanol and a high sensitivity for inhibition by pyrazole and its four-
substituted derivatives (Edenberg & Bosron 1997).  As demonstrated in Tables 1, 2 and 
3, Class I isoenzymes display unique substrate specificities which are derived from amino 
acid differences within the substrate binding site [Table 4].   
While the αα isoenzyme is the least efficient Class I isoenzyme at ethanol 
oxidation, it is highly efficient at cyclohexanol oxidation (2800-fold and 3.5-fold higher 
compared to ββ and γγ, respectively) [Table 3].  The presence of alanine at position 93 
instead of phenylalanine creates a more favorable environment for secondary alcohol 
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binding by creating more space in the substrate binding site [Table 4; Figure 2] (Gibbons 
& Hurley 2004). 
Of all three Class I ADH isoenzymes, human ββ demonstrates the lowest Km for 
ethanol [Table 1], and the lowest catalytic efficiency (Vmax/Km) for cyclohexanol [Table 
3].  In contrast, γγ demonstrates catalytic efficiencies that increase with increasing 
substrate chain length among primary alcohols, as well as a 790-fold increase in Vmax/Km 
value for cyclohexanol compared to ββ [Table 3].  The amino acid substitution of 
threonine for serine at position 48 is essentially responsible for the kinetic differences 
between ββ and γγ, respectively [Table 4] (Hoog et al. 1992).  The presence of serine at 
position 48 in γγ provides a larger space for bulkier substrates like cyclohexanol [Figure 
3-A] (Hoog et al. 1992).  Furthermore, this larger space accounts for the increased 
catalytic efficiencies of longer-chain substrates—where these substrates seem to fill the 
substrate binding pocket and interact more favorably with the enzyme (Light et al. 1992).  
Figure 3-A clearly displays the inner, middle, and outer regions of the γγ substrate 
binding pocket.  As demonstrated, positions 48 and 93 reside along the innermost part of 
the substrate-binding site (right-center).  Moving outward (left), amino acids at positions 
in the middle region are visible (Val-294 and Ile-318).  Continuing outward, the figure 
demonstrates the relative positions of Leu-57 and Leu-116 in the outer region of the 
binding pocket, where the surface of the enzyme is approached.   
Figure 3-B displays a top view of the γγ binding site—where amino acids residing 
in the middle and outer regions are more visible.  As demonstrated, side chains in the in 
the outer region (Met-306) appear closest to the viewer, whereas the middle region 
appears farther away (Leu-309 and Val-141).   
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The Class II ADH isoenzyme is expressed primarily in the liver and at lower 
levels in the lower gastrointestinal tract and spleen (Edenberg 2000).  The ππ isoenzyme 
has a high Km for ethanol and lower Km values for medium chain alcohols [Table 1] 
(Bosron et al. 1979; Eklund et al. 1990).  Residues in the substrate pocket of the Class II 
isoenzymes are longer than approximately half of the corresponding positions in 
comparison to Class I isoenzymes.  The inner part of the substrate cleft is smaller than in 
Class I because Phe-93 is replaced by Tyr-93 [Table 4]—making the substrate site 
distinctly smaller than in Class I subunits.  The narrow hydrophobic substrate binding site 
of ππ makes it well-designed for long aliphatic alcohols as substrates [Table 3] (Eklund et 
al. 1990).     
Class III isoenzymes are ubiquitously expressed (Hur & Edenberg 1995).  While 
the inner part of the χχ substrate-binding cleft is narrow (due to Tyr-93), the outer part is 
considerably wider and more polar than in the Class I and Class II isoenzymes (Eklund et 
al. 1990).  This isoenzyme is probably not involved in ethanol oxidation because the Km 
exceeds 2.0 M (Wagner et al. 1984).  χχ is a long-chain ADH that also catalyzes the 
glutathione-dependent oxidation of formaldehyde (Koivusalo et al. 1989).  However, its 
primary functional role is the metabolism of glutathione adducts (Holmquist & Vallee 
1991).  
Class IV is the only ADH not expressed in the liver.  It is the major ethanol-active 
form present in the stomach; it is also found at high levels in the upper gastrointestinal 
tract (including esophagus, gingiva, mouth and tongue) and in the cornea and epithelial 
tissues (Edenberg 2000).  Human σσ exhibits a high Km for ethanol and lowered Km 
values for longer chain alcohols [Table 1].  However, the catalytic efficiencies are high 
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with ethanol and increase as substrates increase in chain length [Table 3].  These kinetic 
properties arise from the presence of methionine at position 141—which relieves steric 
hindrance in the substrate binding site—yielding more room for larger substrates  [Table 
4; Figure 4-A] (Xie & Hurley 1999).  In addition to being involved in the first-pass 
metabolism of ethanol, σσ is also the most efficient human ADH with respect to retinol 
oxidation (Yang et al. 1994).      
     3. Primate Evolution and ADH gene duplication 
There is a single Class I ADH gene in vertebrates throughout the evolutionary tree 
up through primates; where gene duplication increases the number of Class I isozymic 
forms to two or more.  The current consensus from published literature is that the first 
Class I ADH gene duplication occurred during mammalian radiation, followed by a 
second duplication that probably occurred around or just before the emergence of 
prosimians.  Thus, at least the second duplication event of the Class I ADH genes 
occurred within the primate lineage (Oota et al. 2007).  Furthermore, the absence of 
ADH6 is also primate-specific.  Given that ADH1 and ADH6 are adjacent to each other 
on Chromosome 4, it is possible that the duplication of ADH1 occurred in parallel to the 
loss of ADH6 in primates (Hoog & Ostberg 2011). 
Recent research from the Benner group reveals the presence of four ADH1 
paralogs in the primates, marmoset and macaque [Figure 5] (Carrigan et al. 2012, 
unpublished ).  This finding suggests that during the course of primate evolution, multiple 
duplication events occurred which resulted in the formation of four Class I ADH paralogs 
[Figure 5].  This event is believed to have occurred prior to the divergence of Old World 
and New World monkeys, but after the divergence of strepsirhines (lemurs) from 
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haplorhines (prosimian tarsiers, NWMs, and the Catarrhini—OWMs, gibbons, 
orangutans, gorillas, chimpanzees, and humans).  The absence of this fourth novel 
paralog in all remaining primates indicates that one of the paralogs was lost during the 
remainder of their evolution. 
The basal radiation of primates occurred 63-90 million years ago (Martin 1993; 
Gingerich & Uhen 1994; Tavare et al. 2002).  This was followed by the initial radiation 
of lemuriform primates (prosimians); which is estimated to have occurred approximately 
62 million years ago in Madagascar (Yoder & Yang 2004).  However, the next 
divergence event within the lemuriform radiation did not occur until approximately 42-43 
million years ago, when prosimians and New World monkeys diverged from a common 
ancestor [Figure 6] (Yoder & Yang 2004).   
 New World monkeys (which include present-day marmosets) share a long period 
of common ancestry with the Catarrhini, and the divergence of these two groups occurred 
35-40 million years ago [Figure 6] (Cronin & Sarich 1978).  Yet, the marmoset radiation 
didn’t begin until 7-10 million years ago (Cronin & Sarich 1978). 
 Due to the fact that not all primate genomes have been sequenced to date, the 
exact number and type of Class I ADH genes present in existing primates is unknown.  
However, with the use of NCBI, basic Class I ADH information for specific primate 
species was able to be determined.  The number of Class I ADH paralogs was found to 
vary amongst prosimians; revealing two ADH1s in the bush baby, three ADH1s in both 
the mouse lemur and sifaka, and four ADH1 paralogs in the ring-tailed lemur.  While no 
information on brown lemur ADH1 paralogs was obtained via NCBI, research performed 
for this thesis revealed the presence of at least two Class I ADHs in this species.  The 
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marmoset (a NWM) was recently discovered to have four ADH1 paralogs, as previously 
described (Carrigan et al. 2012, unpublished).  While search results for Class I ADHs in 
OWMs yielded only two paralogs in the baboon (ADH1B-type and ADH1C-type), five 
paralogs (one of which is believed to be a pseudogene) were recently discovered in the 
macaque (Carrigan et al. 2012, unpublished).  Finally, while northern gibbons, gorillas, 
chimpanzees, and humans all have three Class I ADHs (ADH1A, ADH1B, and ADH1C); 
orangutans appear to only have two (ADH1A and ADH1C) [Figure 5]. 
 As demonstrated in Figure 5, humans and chimpanzees (both of which have three 
Class I ADH genes) diverged from a common ancestor approximately 7 million years ago 
(Flotte et al. 2010).  However, the two probably had a similar diet up until about 2 
million years ago (Gaulin & Konner 1977; Grine & Kay 1988); as dietary diversification 
is believed to have characterized human evolution over the past 2 million years (Eaton et 
al. 1997; Milton 1999; Sponheimer & Lee-Thorp 1999). Furthermore, since humans are 
ancestrally-derived from frugivorous primates, the preference for and excessive 
consumption of alcohol by modern humans may ultimately result from pre-existing 
sensory biases associating ethanol with nutritional reward (Dudley 2004).  
     4. Diets/Habitats of Brown Lemurs and Marmosets 
 The common brown lemur (Eulemur fulvus) is an arboreal primate endemic to the 
rainforests and dry forests of Madagascar and Mayotte (Klopfer 1970; Klopfer & Jolly 
1970).  These opportunistic foragers show a preference for fruits—regardless of the 
season—and supplement their diet with flowers and leaves (Tarnaud 2004). 
 The common marmoset (Callithrix jacchus, a small-bodied New World primate) 
inhabits predominantly secondary or disturbed forests, open woodlands, and savanna/dry 
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forest formations of northeastern and southern Brazil (Ferrari & Lopes Ferrari 1989).  
The common marmoset is considered among the most specialized gum-feeders (Caton et 
al. 1996; Coimbra Filho & Mittermeier 1978) and has been classified as an obligate 
exudativore (Garber 1992).  However, when fruit is plentiful, marmosets may reduce 
their gum intake in favor of fruit and will also consume arthropods when available 
(Rylands 1984).  
     5. Alcohol-related Diseases 
 The intentional production of alcoholic beverages is currently prevalent 
throughout an array of human cultures world-wide.  Furthermore, yeasts have been used 
by humans for thousands of years for fermenting food and beverages; yet fermentations 
were probably initiated by naturally-occurring yeasts in Neolithic times, and it is 
unknown when humans began to consciously add selected yeast to make beer or wine 
(Sicard & Legras 2011).  While the moderate and/or occasional consumption of alcoholic 
beverages isn’t generally believed to lead to any major health issues, it has been proved 
that excessive alcohol consumption can lead to harmful physical and mental effects. 
 A. Alcoholism 
 Alcoholism is currently recognized as a disease characterized by impaired 
regulation of alcohol consumption that ultimately leads to: (1) impaired control over 
drinking; (2) tolerance; (3) psychological dependence (craving); and (4) physical 
dependence (withdrawal signs upon cessation).  The CAGE questions have proved useful 
in helping to make a diagnosis of alcoholism; where the acronym “CAGE” consists of 
questions which focus on Cutting down, Annoyance by criticism, Guilty feeling, and 
Eye-openers (Ewing 1984).  This complex disease is affected by both environmental and 
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genetic factors.  Currently the only genes that have been firmly linked to vulnerability to 
alcoholism are the ones encoding the alcohol and aldehyde dehydrogenases (Li 2000).  
Specific ADH and ALDH genes also affect risk for complications associated with alcohol 
abuse; including alcoholic liver disease, digestive tract cancer, heart disease, and fetal 
alcohol syndrome (Hurley et al. 2002). 
 B. Alcoholic Liver Disease 
 It is evident that the development of alcoholic liver disease (ALD) is related to the 
amount and duration of alcohol intake; furthermore, since not everyone exposed to 
equivalent amounts of alcohol develops ALD, underlying genetic factors are ultimately 
responsible for host susceptibility (Hurley et al. 2002).  It is evident that oxidative stress 
plays an important role in the pathogenesis of ALD; where the main source of free 
oxygen species is cytochrome P450-dependent monooxygenase, which can be induced by 
ethanol (Radosavljevic et al. 2009). 
 The first and most common hepatic change caused by alcohol consumption is 
steatosis, or fatty liver.  Hepatic fat accumulation can invoke metabolic changes that 
sensitize the liver to further injury (Beier & Arteel 2012).  The next stage of ALD that 
may develop is steatohepatitis—characterized histologically by both macro- and 
microvesicular steatosis, and infiltration of inflammatory cells, as well as hepatocyte 
degeneration, ballooning, necrosis, and apoptosis (Ramaiah et al. 2004).  Like simple 
steatosis, steatohepatisis is also reversible with cessation of alcohol abuse; however, the 
reversion can take several weeks to months, as opposed to a few days (Hill & Kugelmas 
1998).  The final stages of ALD include fibrosis and cirrhosis.  Fibrosis is characterized 
by deposition of extracellular matrices, or ECMs (Schuppan et al. 2001).  If alcohol 
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intake persists past fibrosis, cirrhosis can develop—which consists of hepatic scarring (as 
with fibrosis, but more extensive), altered liver parenchyma with septae and nodule 
formation, and distorted hepatic blood flow (Friedman 2008; Kim et al. 2002).  Upon 
cirrhosis development, death will probably occur without a liver transplant (Kim et al. 
2002).  
 C. Cancer 
 An increased risk for upper aerodigestive tract (oral cavity, pharynx, larynx, and 
esophagus), stomach, and colorectal cancers are associated with high levels of chronic 
alcohol consumption.  In essence, acetaldehyde causes point mutations in DNA and 
induces sister chromatid exchanges and abberations; thus having direct mutagenic and 
carcinogenic effects (Dellarco 1988).  
 Many studies have shown that the ALDH2*2 allele is associated with an increased 
risk of ethanol-associated digestive tract cancers; while some studies have found an 
association of ADH1B*1 and ADH1C*2 with an increased risk for oropharyngeal cancer 
(Yokoyama et al. 1998; Olshan et al. 2001). 
 D. Fetal Alcohol Syndrome 
 Fetal alcohol syndrome (FAS) is a pattern of birth defects caused by maternal 
ethanol consumption during pregnancy.  FAS is recognized by growth deficiency, a 
characteristic set of craniofacial features, and neurodevelopmental abnormalities leading 
to cognitive and behavioral deficits (Stratton et al. 1996).  While it is evident that alcohol 
is an environmental teratogen, it is unclear which principal agent (ethanol itself or 
acetaldehyde) triggers the developmental abnormalities in the brain during gestation 
(Hurley et al. 2002).    
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However, it is known that retinol and ethanol are competitive substrates for 
oxidation by ADH to retinal and acetaldehyde, respectively; furthermore, retinoic acid—
derived from vitamin A (retinol)—is essential for controlling the normal patterns of 
development of tissues and organs (Deltour et al. 1999).   
     6. Specific Aims 
 The overlying hypothesis of this thesis is that the evolution of ethanol oxidizing 
capability amongst primates is driven by dietary factors and that alcohol dehydrogenase 
isoenzymes evolved in a manner to increase their catalytic efficiency toward small 
substrates like ethanol due to increased prevalence of fermented alcohols present in 
ripened fruit. Research for this thesis focused on the enzymatic properties of multiple 
Class I ADH isoenzymes from two modern-day primates with distinct dietary habits, in 
addition to the enzymatic properties of different Class IV ADH isoenzymes resurrected 
from human ancestors.  The protein sequences from primate ADH isoenzymes were 
compared to human Class I isoenzymes [Table 5], while protein sequences from ancestral 
ADH isoenzymes were compared to the human Class IV isoenzyme [Table 6] utilizing 
the BLAST tool. Next, enzymatic properties obtained via kinetic assays and structural 
analysis were compared to ADH isoenzymes of modern-day humans in order to 
determine the efficiency of alcohol metabolism—especially ethanol metabolism—among 
respective species.  This information was ultimately used in order to determine when and 
why ADH isoenzymes duplicated and diverged during the evolution of primates. 
 We chose to examine multiple Class I ADH isoforms from primate species with 
distinct dietary preferences (brown lemur and marmoset) in an effort to correlate diets 
rich in fermentable fruits with increased catalytic capacity toward ethanol oxidation.  The 
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ancestral Class IV ADH isoforms were selected from two nodes common to humans, 
which are known to possess isoenzymes containing alanine at position 294 [Figure 7].  
Since modern humans possess a Class IV isoform containing valine at this position, 
Sigma 2-1 and Sigma 2-2 were chosen in an effort to determine the effect/magnitude of 
change in catalytic capacity toward ethanol oxidation caused by this single amino acid 
exchange—which is believed to have occurred approximately 15 million years ago in 
primate evolution – and may be the major contributor to the increased capacity of human 
Class IV ADH to oxidize ethanol. 
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Table 1: Km Constants (mM) of Human ADH Isoenzymes at pH 7.5 
 
 
 
Table 2: Vmax Constants (min-1) of Human ADH Isoenzymes at pH 7.5 
 
 
 
Table 3: Vmax/Km Values (min-1mM-1) of Human ADH Isoenzymes at pH 7.5 
 
 
 
(All data was rounded to 2 significant figures.) 
 
 
1. (Stone et al. 1989)                                                                                                                                          
2. (Hurley & Bosron 1992)                                                                                         # = No activity 
3. (Kedishvili et al. 1995)                                                                                           * = No saturation 
4. (Eklund et al. 1987); measured at pH 10.0                                                             ~ = Not determined 
Ethanol 6.1 0.05 0.33 28 * 120
Propanol 0.6 0.019 ~ 1.4 ~ ~
Butanol 0.032 0.012 0.04 0.79 ~ ~
Pentanol 0.014 0.019 0.02 0.28 22 0.09
Hexanol ~ 0.022 ~ 0.13 8.2 ~
Trans -2-hexen-1-ol ~ ~ ~ 0.018 ~ ~
Cyclohexanol 0.012 3.9 0.063 ~ # 210
SU
B
ST
R
A
T
E
S
Human ADH 
isoenzymes→ αα
1,2           ββ1,2 γγ1 σσ3 χχ4 ππ4
Ethanol 16 4.0 49 1,800 * 470
Propanol 22 3.0 ~ 1,000 ~ ~
Butanol 20 2.9 74 2,100 ~ ~
Pentanol 15 3.6 68 960 240 480
Hexanol ~ 4.4 ~ 1,200 130 ~
Trans -2-hexen-1-ol ~ ~ ~ 2,200 ~ ~
Cyclohexanol 25 3.0 38 ~ ~ 35
ππ4
SU
B
ST
R
A
T
E
S
Human ADH 
isoenzymes→ αα
1,2           ββ1,2 γγ1 σσ3 χχ4
Ethanol 2.7 80 150 65 * 4
Propanol 36 160 ~ 570 ~ ~
Butanol 640 240 1,800 2,600 ~ ~
Pentanol 1,100 190 3,400 3,400 11 5,300
Hexanol ~ 200 ~ 9,000 16 ~
Trans -2-hexen-1-ol ~ ~ ~ 120,000 ~ ~
Cyclohexanol 2,100 0.76 600 ~ # 0.2
χχ4 ππ4
SU
B
ST
R
A
T
E
S
αα1,2           ββ1,2 γγ1 σσ3
Human ADH 
isoenzymes→
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Table 4: Amino Acids Present in the Substrate Site of Human ADHs 
 
 
 
 
  
REGION Position II III IV
αα ββ γγ ππ χχ σσ
48 Thr Thr Ser Thr Thr Thr
93 Ala Phe Phe Tyr Tyr Phe
141 Leu Leu Val Phe Met Met
294 Val Val Val Val Val Val
309 Leu Leu Leu Ile Val Phe
318 Ile Val Ile Phe Ala Val
57 Met Leu Leu Phe Asp Met
116 Val Leu Leu Asn Val Ile
306 Met Met Met Glu Phe Met
Human Class I
INNER
MIDDLE
OUTER
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Table 5: % Sequence Identity between Human and Ancestral Class IV ADH 
Isoenzymes 
 
 
 
 
 
 
 
Table 6: % Sequence Identity between Human and Primate Class I ADH 
Isoenzymes 
 
 
 
  
98%
99% 98%
Human σσ Sigma 2-1 Sigma 2-2
97% 99%
97%
H
um
an
 
σ
σ
Si
gm
a 
   
  
2-
1
Si
gm
a 
   
   
2-
2
89%
86% 85% 87% 83% 85% 89%
93% 90% 87% 85%
87% 86% 87% 86% 87%
93% 87% 87%
90% 93% 93% 90% 86% 83%
86%
94% 94% 93% 91% 86% 85%
4B
22B
94%
93% 94%
90% 91%
ADH1A
ADH1B
ADH1C
2M
10M
93% 90% 90% 87%
ADH1C 2M 10M 4B 22B
93%
ADH1A ADH1B
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Figure 1: Human γγ-ADH Dimer 
 
 
 
 
  
Figure 1 
 
-Ribbons diagram of 
human γγ -ADH with 
different colors 
representing different 
subunits (teal and green). 
-Bound coenzyme 
molecules are displayed in 
magenta. 
-Generated with PyMOL. 
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Figure 2: Human αα-ADH Substrate Site 
 
 
 
 
  
Figure 2 
 
-Side view of human αα-
ADH displaying Ala-93 in 
the Inner Region, Val-294 
in the Middle Region, and 
Val-116 in the Outer 
Region of the substrate 
binding site. 
-The Phe→Ala substitution 
at position 93 results in 
extra space in the substrate 
binding site compared to 
ββ-ADH and γγ-ADH.  
-Generated with PyMOL. 
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Figure 3: Human γγ-ADH 
A. Side View of Substrate Site 
 
B. Top View of Substrate Site 
 
 
Figure 3-A 
 
-Side view of humanγγ-
ADH displaying Ser-48 
and Phe-93 in the Inner 
Region, Val-294 and Ile-
318 in the Middle Region, 
and Leu-57 and Leu-116 
in the Outer Region of the 
substrate binding site. 
-Generated with PyMOL. 
Figure 3-B 
 
-Top view of huma γγ-
ADH displaying Phe-140, 
Val-141 and Leu-309 in 
the Middle Region, and 
Met-306 in the Outer 
Region of the substrate 
binding site. 
-Generated with PyMOL. 
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Figure 5: Phylogenetic Relationship of ADH1 Paralogs1 
 
 
 
 
 
 
 
Figure 5.  Phylogenetic relationship of ADH1 paralogs as determined by Bayesian analysis of exonic 
sequence data using a codon model, including strepsirrhines (lemurs, orange); platyrrines (New World 
primates, pink), and catarrhines (Old World primates and hominoids, red).  The human ADH2, ADH3, 
ADH4 and ADH5 genes were used as representatives for mammalian ADH Class I - V.  Neither chicken 
(Gallus gallus) nor frog (Xenopus tropicalis) representatives of the mammalian ADH Class II proteins were 
found in the public nucleotide databases, suggesting that either (1) these genes have not yet been sequenced 
in both chicken and frog, (2) the ADH Class II homolog has been lost in both chicken and frog, or (3) the 
position of the human ADH2 gene is incorrect in this tree (and should instead either be sister to human 
ADH3 or branch after the chicken ADH Z and ADH Y clade). 
 
 
1. (Carrigan et al. 2012, unpublished ) 
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Figure 6: Primate Evolutionary Divergence Timeline1 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Figure derived from data in (Flotte et al. 2010). 
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Figure 7: Primate Cladogram displaying the Nodes from which Ancestral Class IV 
ADHs were resurrected 
 
 
 
 
Sigma 2-1 
Sigma 2-2 
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II. METHODS 
     1. Protein Purification 
The Protein Expression Core Facility at IUPUI was responsible for preparing the 
vector designs and performing protein purification protocols for all enzymes used in 
experiments.  ADH enzymes 4B, 22B, Sigma 2-1, and Sigma 2-2 were all expressed and 
purified following the same protocol—described below.  The vector, pET41a-his, was 
used to express recombinant 4B, Sigma 2-1, and Sigma 2-2; while pET28a-his was used 
to express recombinant 22B.   
Cultures of E. coli transformed with the appropriate expression vector were grown 
overnight at 37ºC in 20 ml of LB media (containing 50 µg/ml of Kanamycin).  20 ml of 
the overnight culture was then added to 1,000 ml of LB media (containing 50 µg/ml of 
Kanamycin), and allowed to grow at 37ºC to an OD600 of 0.5.  Expression of the protein 
was induced by the addition of both IPTG (isopropyl-β-D-thiogalactopyranoside, 0.1 mM 
final concentration), and ZnSO4 (to a final concentration of 10 µM); which was incubated 
at 16ºC for an additional 16 hours.  The cells were then harvested by centrifugation, and 
the resulting pellet was stored at -80ºC. 
In order to lyse the cells for protein purification, the cell pellet was thawed on ice, 
and cells were resuspended in 25 ml of lysis buffer (50 mM Tris, 0.3 M NaCl, 10 mM 
Imidazole, 2 mM Benzamidine [pH 8.0]).  The resuspended cells were lysed by passage 
through a French Pressure cell operated at 13,000 psi; followed by centrifugation to 
clarify the lysate.  The clarified lysate present in the supernatant was saved and 
transferred to a new tube for protein purification.  
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 For protein purification, 2 ml of Ni-NTA-Superflow resin, equilibrated in lysis 
buffer, was added to the lysate supernatants and mixed gently by rotation at 4ºC for 2 
hours.  The resin was then centrifuged, the supernatant saved and then the resin was 
washed with three volumes of lysis buffer,and centrifuged again.  Next, 40 ml of buffer A 
(50 mM Tris, 0.3 M NaCl, 20 mM Imidazole, 1 mM Benzamidine [pH 8.0]) was added to 
resuspend the Ni-NTA resin.  This Ni-NTA mixture was then poured into a column, and 
washed with 50 ml of buffer A, and then with 100 ml of buffer B (50 mM Tris, 0.3 M 
NaCl, 30 mM Imidazole, 1 mM Benzamidine [pH 8.0]) to remove non-specifically bound 
proteins..  Finally, the ADH proteins were eluted with addition of four, 0.5-ml aliquots of 
Elution buffer (50 mM Tris, 0.3 M NaCl, 200 mM Imidazole, 1 mM Benzamidine [pH 
8.0]). 
 The activities of the fractions were measured via spectrophotometer using 
standard ADH assays, and analyzed by SDS-PAGE.  Fractions were then concentrated 
and buffer-exchanged with 10 mM Tris (pH 8.0), and 1 mM DTT—using a Micron 30 
concentrator (Amicon, Beverly, MA).  Protein was then either aliquotted and flash-
freezed in liquid nitrogen (and stored at -80ºC), or aliquotted and stored at -20ºC in a 
50% (v/v) glycerol solution.  If stored in a glycerol solution, a gel-filtration column was 
used to remove glycerol before kinetic analysis.   
     2. Activity Assay and Enzyme Kinetics 
A Beckman DU-640 spectrophotometer was used to monitor alcohol 
dehydrogenase activity for the enzymes.  The spectrophotometer utilized an extinction 
coefficient of 6.22 mM-1cm-1 at 25ºC, for production of NADH at 340 nm.  
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The assay used for each experiment measured duplicate enzyme cuvettes, which 
contained final concentrations of the following reagents: 100 mM sodium phosphate (pH 
7.5), 2.5mM NAD+,  alcohol substrate (0.015 mM-450.0 mM), and enzyme (16.8 µM-
1030 µM).  The blank cuvette, which was used for each measurement, contained all 
reagents in the reaction mixture except for the substrate.  Reaction buffer (100 mM 
sodium phosphate [pH 7.5]) was prepared as-needed (typically every 3-4 weeks); and 75 
mM NAD+ was prepared daily with reaction buffer and added to the reaction cuvettes to 
yield final concentrations of 2.5 mM.  Alcohol stock solutions were initially prepared 
with MilliPore grade H2O.  These stock solutions lasted throughout the duration of all 
experiments.  Dilutions were made with reaction buffer from these stock solutions as 
needed—in order to obtain the desired final substrate concentrations.  Stock solutions 
were made by diluting pure alcohols to yield final volumes of 100 ml each.  Ethanol 
(58.69 ml/mol), which was purchased from AAPER Alcohol & Chemical Co. 
(Shelbyville, KY), was diluted to yield a final stock concentration of 1 M.  Propanol 
(75.14 ml/mol) was diluted to yield a stock of 1 M; butanol (91.97 ml/mol) to 0.25 M; 
pentanol (108.63 ml/mol) to 0.05 M; hexanol (125.23 ml/mol) to 0.025 M; cyclohexanol 
(104.01 ml/mol) to 0.05 M, and trans-2-hexen-1-ol (129.8 ml/mol) to 0.025 M. 
 Reaction buffer, NAD+, and the desired alcohol substrates were each added to 
cuvettes, respectively.  The reaction was then initiated upon addition of enzyme.  This 
addition allowed for the spectrophotometer to measure the rate of NADH production; 
determined by calculating the initial velocity during the first 60 seconds of the reaction.   
The Km and Vmax values for each enzyme and substrate were calculated using the 
results from triplicate experiments.  The calculated average Vmax values were then 
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divided by the initial protein concentration added, and multiplied by mg/µmole of 
enzyme; thus resulting in units of µmoles of NADH produced per minute, per µmole of 
enzyme active sites.  The data obtained from the spectrophotometer was in Units (U) per 
milliliter.  The final Vmax values were obtained with use of the following equations: 
1 Unit (U)enzyme = 1 μmole NADH 
min
 
& 
U
ml
mg
ml
 = 
U
mg
 = 
μmoles/min
mg
 × 
40 mg (enzyme)
μmole
 
 
 A. 4B Assays 
Substrates used in 4B experiments included the primary alcohols ethanol, 
propanol, butanol, pentanol, hexanol, and trans-2-hexen-1-ol, as well as the secondary 
alcohol cyclohexanol.  Experiments for all substrates contained final protein 
concentrations of 0.75 µM, except for trans-2-hexen-1-ol—containing a final protein 
concentration of 0.25 µM.  An ethanol stock solution of 1 M was used to create a 20 mM 
ethanol solution, which was then used to create ethanol experiments at concentrations of 
0.15 mM, 0.25 mM, 0.50 mM, 1.0 mM, and 2.0 mM.  A 20 mM propanol solution was 
used to create experiments at concentrations of 0.075 mM, 0.30 mM, 0.75 mM, 1.0 mM, 
and 2.5 mM.  A 20 mM butanol solution was used to create experiments at concentrations 
of 0.10 mM, 0.40 mM, 1.0 mM, 2.0 mM, and 5.0 mM.  A 20 mM pentanol solution was 
used to create experiments at concentrations of 0.10 mM, 0.40 mM, 1.0 mM, 2.0 mM, 5.0 
mM, and 10.0 mM.  A 20 mM hexanol solution was used to create experiments at 
concentrations of 0.10 mM, 0.40 mM, 1.0 mM, 2.0 mM, and 5.0 mM.  A 50 mM 
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cyclohexanol solution was used to create experiments at concentrations of 5.0 mM, 7.5 
mM, 10.0 mM, 20.0 mM, and 40.0 mM.  A 2 mM trans-2-hexen-1-ol solution was used 
to create experiments at concentrations of 0.025 mM, 0.50 mM, 0.075 mM, 0.10 mM, 
0.20 mM, 0.40 mM, and 1.0 mM.  
 B. 22B Assays 
Substrates used in 22B experiments included the primary alcohols ethanol, 
propanol, butanol, pentanol, hexanol, and trans-2-hexen-1-ol, as well as the secondary 
alcohol cyclohexanol.  All substrates utilized final 22B enzyme concentrations of 0.9 µM.  
A 20 mM ethanol solution was used to create ethanol experiments at concentrations of 
3.0 mM, 5.0 mM, 7.5 mM, and 15.0 mM; while 1 M of ethanol stock solution was used 
to create ethanol experiments at concentrations of 20.0 mM and 40.0 mM.  A 10 mM 
propanol solution was used to create propanol experiments at concentrations of 0.25 mM, 
0.50 mM, 0.75 mM, and 1.5 mM; while 20 mM of propanol solution was used to create 
experiments at concentrations of 3.0 mM and 8.0 mM.  A 10 mM butanol solution was 
used to create butanol experiments at concentrations of 0.20 mM, 0.30 mM, 0.60 mM, 
1.0 mM, 1.25 mM, and 2.0 mM.  A 10 mM pentanol solution was used to create pentanol 
experiments at concentrations of 0.25 mM, and 0.35 mM; while 50 mM pentanol stock 
solution was used to create pentanol experiments at concentrations of 0.60 mM, 1.25 
mM, and 2.0 mM.  A 20 mM hexanol solution was used to create hexanol experiments at 
concentrations of 0.10 mM, 0.20 mM, 0.30 mM, 0.60 mM, 1.0 mM, and 2.0 mM.  A 25 
mM cyclohexanol solution was used to create cyclohexanol experiments at 
concentrations of 0.50 mM, 1.5 mM, 3.0 mM, 5.0 mM, and 5.5 mM.   A 2 mM trans-2-
hexen-1-ol solution was used to create trans-2-hexen-1-ol experiments at concentrations 
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of 0.015 mM, 0.02 mM, 0.025 mM, and 0.04 mM; while a 10 mM trans-2-hexen-1-ol 
solution was used to create trans-2-hexen-1-ol experiments at concentrations of 0.05 
mM, and 0.10 mM. 
C. Sigma 2-1 Assays 
Substrates used in Sigma 2-1 experiments included only the primary alcohols 
ethanol, propanol, butanol, pentanol, hexanol, and trans-2-hexen-1-ol.  Ethanol, 
propanol, and butanol experiments used final protein concentrations of 0.41 µM; pentanol 
and hexanol experiments used final protein concentrations of 1.03 µM; and trans-2-
hexen-1-ol experiments used final protein concentrations of 0.02 µM. A 1 M ethanol 
stock solution was used to create ethanol experiments at concentrations of 25.0 mM, 80.0 
mM, 175.0 mM, 275.0 mM, and 350.0 mM.  A 1 M propanol stock solution was used to 
create propanol experiments at concentrations of 80.0 mM, 175.0 mM, 275.0 mM, 350.0 
mM, and 450.0 mM. A 250 mM butanol stock solution was used to create butanol 
experiments at concentrations of 50.0 mM, 100.0 mM, 150.0 mM, 200.0 mM, and 225.0.  
A 50 mM pentanol stock solution was used to create pentanol experiments at 
concentrations of 2.5 mM, 10.0 mM, 25.0 mM, 35.0 mM, and 45.0 mM.  25 mM of 
hexanol stock solution was used to create hexanol experiments at concentrations of 1.0 
mM, 2.5 mM, 5.0 mM, 15.0 mM, and 23.0 mM.  A 25 mM trans-2-hexen-1-ol stock 
solution was used to create trans-2-hexen-1-ol experiments at concentrations of 0.10 
mM, 0.50 mM, 2.0 mM, 5.0 mM, and 10.0 mM.  
D. Sigma 2-2 Assays 
Substrates used in Sigma 2-2 experiments included only the primary alcohols 
ethanol, propanol, butanol, pentanol, hexanol, and trans-2-hexen-1-ol.  Ethanol, 
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propanol, and butanol experiments had final protein concentrations of 0.20 µM; pentanol 
experiments had final protein concentrations of 0.10 µM; hexanol and trans-2-hexen-1-ol 
experiments had final protein concentrations of 0.017 µM.  A 500 mM ethanol solution 
was used to create ethanol experiments at concentrations of 15.0 mM, 35.0 mM, 55.0 
mM, 75.0 mM, 100.0 mM and 140.0 mM.  A 500 mM propanol solution was used to 
create propanol experiments at concentrations of 15.0 mM, 35.0 mM, 55.0 mM, 75.0 
mM, 100.0 mM and 140.0 mM.  A 250 mM butanol stock solution was used to create 
butanol experiments at concentrations of 15.0 mM, 20.0 mM, 30.0 mM, 60.0 mM, 90.0 
mM, and 140.0 mM.  A 50 mM pentanol stock solution was used to create pentanol 
experiments at concentrations of 1.0 mM, 2.5 mM, 10.0 mM, 15.0 mM, 20.0 mM and 
35.0 mM.  A 25 mM hexanol stock solution was used to create hexanol experiments at 
concentrations of 1.0 mM, 2.5 mM, 5.0 mM, 10.0 mM, 15.0 mM and 23.0 mM.  A 2 mM 
trans-2-hexen-1-ol  solution was used to create trans-2-hexen-1-ol experiments at 
concentrations of 0.10 mM, 0.30 mM, 0.50 mM, 1.0 mM, 3.0 mM, and 5.0 mM.  
     3. Analysis of Steady-State Kinetic Parameters 
Data obtained from the kinetic experiments was fit to the Michaelis-Menton 
equation displayed below, using the software package Sigma Plot Enzyme Kinetics 
Package (Version 10.0): 
v=
Vmax×  [S]
Km+ [S]  
 
     4. Reagents 
All reagents used were purchased from Sigma-Aldrich (St. Louis, MO); unless 
otherwise noted.  
31 
 
     5. Modeling 
 Modeling of the ADH isoenzymes was performed using Swiss-PdbViewer 
(Version 4.0.4) and PyMOL (Version 1.4.1) and either the coordinates of human β1β1 
alcohol dehydrogenase complexed with coenzyme and heptylformamide (RCSB code 
1U3V), human γ2γ2 alcohol dehydrogenase complexed with coenzyme and 
methylheptylformamide (RCSB code 1U3W) or human σσ alcohol dehydrogenase 
(RCSB code 1D1S).  Human ADH amino acid sequences were manipulated by 
substituting amino acids at positions in the substrate binding site in order to correspond to 
sequences from brown lemur, marmoset, and human ancestral isoenzymes.  Next, 
respective sequences were generated in Swiss-PdbViewer using the mutate function and 
utilizing the rotamer selection to minimize contacts with surrounding residues.  The final 
models/figures were generated using PyMOL and used to demonstrate structural 
similarities and differences between select isoenzymes.   
     6. Determining Class I ADH Genes among Primates 
 The NCBI website was used to determine the number and type of Class I ADH 
genes present among various existing primates by first performing a protein search for 
human (ADH1A, ADH1B, or ADH1C), and then performing sequence match searches for 
respective isoenzymes via BLAST.  Results demonstrating at least 85% sequence identity 
between species were considered to be matches (homologous).  
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III. RESULTS 
     1. Enzymes: 2M, 10M, 4B, and 22B  
 A. Ethanol, Propanol, Butanol, Pentanol, and Hexanol as Substrates 
 For the 2M isoenzyme from Marmoset, the values for Km, Vmax, and Vmax/Km 
(catalytic efficiency) amongst the primary aliphatic alcohols (ethanol, propanol, butanol, 
pentanol, and hexanol) were relatively constant, varying by a maximum of 2-fold within 
each group of kinetic constant [Tables 7-9].  The Km values from ethanol to hexanol 
remained almost constant at 0.79 and 0.81 mM for ethanol and hexanol, respectively 
[Table 7].  Similarly, the Vmax values for ethanol, propanol, and butanol remained 
constant, but the Vmax for pentanol and hexanol decreased by approximately 25% [Table 
8].  Not surprisingly, given the constancy of the individual values, the catalytic 
efficiencies for these substrates varied merely 1.4-fold [Table 9]. 
 In contrast to the 2M ADH isoform, the 10M isoenzyme from marmoset exhibited 
Km values that varied in a chain-length dependent manner with a Km for ethanol that was 
12-fold higher than that for hexanol [Table 7].  Similarly, the Vmax also decreased with 
increasing chain length—with the Vmax for ethanol oxidation exceeding that of hexanol 
oxidation by nearly 4-fold [Table 8].  The trend in Vmax/Km for these primary alcohols 
increased as substrate chain-length increased—yielding 3.8-fold higher values for 
pentanol and hexanol compared to that for ethanol [Table 9]. 
 A similar trend was observed with the two ADH isoforms from brown lemur (4B 
and 22B); where one isoenzyme exhibited no large changes in the kinetic constants for 
the aliphatic alcohols, and one enzyme which demonstrated chain-length dependence for 
these kinetic constants [Tables 7-9].  The Km, Vmax, and Vmax/Km values for the 4B 
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isoenzyme for these primary alcohols were relatively constant—varying by a maximum 
of only 2-fold per category.  Km values increased from ethanol to butanol by about 2-fold, 
but then decreased again from butanol to hexanol; such that ethanol and hexanol 
possessed similar Km values [Table 7].  The Vmax for ethanol and propanol were similar, 
while the Vmax decreased with increasing chain length after propanol.  There was about a 
2-fold decrease in the Vmax for hexanol oxidation compared to that for ethanol/propanol 
[Table 8; Figure 8].  The catalytic efficiencies varied by a maximum of 2-fold; ethanol 
and propanol were similar, while butanol was decreased 2-fold relative to propanol.  Both 
pentanol and hexanol had higher catalytic efficiencies than butanol, but lower efficiencies 
than ethanol and propanol [Table 9]. 
 Like the 10M isoenzyme, the 22B isoenzyme exhibited Km values that ranged by 
30-fold; with values decreasing with increasing substrate chain length [Table 7].  The Km 
value for propanol dropped 8-fold relative to ethanol; while the Km values for both 
butanol and pentanol decreased by about 11-fold relative to ethanol.  The Km value for 
hexanol as a substrate was the lowest; decreasing 30-fold relative to that of ethanol.  
Unlike the 10M isoenzyme, the Vmax values for 22B remained relatively constant, varying 
only 1.2-fold [Table 8; Figure 9].  Given the consistency of the Vmax values, the changes 
in the catalytic efficiencies for the 22B isoenzyme were driven by the differences in Km 
for the substrate, and were 26-fold higher for hexanol than for ethanol [Table 9].  The 
catalytic efficiencies increased about 8-fold from ethanol to propanol; then increased 
about 1.5-fold from propanol to butanol/pentanol, and increased again by about 2-fold 
from butanol/pentanol to hexanol. 
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 B. Cyclohexanol as a Substrate 
 Cyclohexanol was a highly variable substrate for these isoenzymes; with some 
almost preferring this secondary alcohol (10M) and others barely oxidizing it (4B).  The 
2M isoenzyme was the second best toward cyclohexanol oxidation, but it was the poorest 
substrate tested with this isoenzyme.  The 2M isoenzyme exhibited a Km value that was 
2-fold higher, compared to that of primary alcohol substrates, a decreased Vmax (about 2-
fold lower than ethanol, propanol, and butanol; but only 25% lower than for 
pentanol/hexanol); and a 4- to 5-fold decrease in Vmax/Km compared to those of primary 
alcohols [Tables 7-9]. 
 The 10M isoenzyme was the best enzyme for oxidation of cyclohexanol; where 
the Km value for cyclohexanol was comparable to that of hexanol and pentanol, and about 
12-fold lower than for that of ethanol [Table 7].  The Vmax for cyclohexanol oxidation 
was slightly lower than for ethanol oxidation, and about 3-fold higher than for hexanol 
[Table 8].  The catalytic efficiency increased significantly with cyclohexanol, and was 3-
fold higher than for the oxidation of pentanol or hexanol; and 11-fold higher than for 
ethanol [Table 9]. 
 The 4B isoenzyme was the poorest enzyme for cyclohexanol oxidation.  The Km 
value for cyclohexanol was increased approximately 40-fold compared to the Km values 
for the primary alcohols [Table 7].  The Vmax for cyclohexanol oxidation was not as 
adversely affect and was comparable to that of hexanol: approximately 2-fold lower than 
that of ethanol or propanol [Table 8; Figure 10-A].  The Vmax/Km for cyclohexanol 
decreased substantially compared to the Vmax/Km for primary alcohols ranging from 58-
fold lower than butanol, to 125-fold lower than ethanol [Table 9].   
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 The 22B and 2M ADH isoenzymes had similar catalytic efficiencies for 
cyclohexanol; but unlike the 2M isoenzyme, cyclohexanol was not the worst substrate 
tested for the 22B isoenzyme.  The 22B isoenzyme exhibited a Km value that was 
increased about 4-fold lower than ethanol, but about 2-fold higher than propanol [Table 
7].  The Vmax for cyclohexanol oxidation was slightly lower than all primary alcohols, but 
within statistical error of most of the primary alcohol oxidation rates [Table 8; Figure 10-
B].  The catalytic efficiency for cyclohexanol oxidation was about 4-fold higher than that 
of ethanol, but decreased between 2- and 7-fold relative to the aliphatic primary alcohols 
[Table 9]. 
 C. Trans-2-hexen-1-ol as a Substrate 
 The unsaturated primary alcohol, trans-2-hexen-1-ol, was the best substrate for all 
primate Class I isoenzymes tested.  When used as a substrate for the 2M isoenzyme, the 
Km for this substrate was approximately 6- to 10-fold lower than that of the primary 
alcohols, including hexanol, its closest structural analog, and was about 20-fold lower 
than for cyclohexanol [Table 7].  The Vmax measured with trans-2-hexen-1-ol as a 
substrate was higher than that of all primary alcohols—increasing by a maximum of 
about 2-fold (relative to pentanol/hexanol) [Table 8].  The Vmax/Km for trans-2-hexen-1-
ol increased significantly compared to the catalytic efficiencies for the primary alcohols 
(12-17 fold increases), and about 58-fold higher than that of cyclohexanol as a substrate 
[Table 9]. 
 For the 10M isoenzyme, the Km value for trans-2-hexen-1-ol was equal to the 
values for both hexanol and cyclohexanol; while the Km was decreased approximately 
12-fold relative to ethanol [Table 7].  The Vmax measured for trans-2-hexen-1-ol as a 
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substrate was higher than those of all of the primary alcohols (up to 5-fold higher than for 
hexanol oxidation, but only 1.4-fold higher than for cyclohexanol oxidation [Table 8].  
The Vmax/Km for trans-2-hexen-1-ol as a substrate was higher than the catalytic 
efficiencies for all primary alcohols, as well as for cyclohexanol—ranging from a 4- to a 
15-fold increase [Table 9].  The catalytic efficiency for trans-2-hexen-1-ol also increased 
about 1.5-fold compared to that of cyclohexanol. 
 When trans-2-hexen-1-ol was used as a substrate for the 4B isoenzyme, the Km 
value was approximately 18-fold lower than Km values for the other primary alcohols, 
and 1000-fold lower than for cyclohexanol [Table 7].  In contrast, the Vmax value was 
similar to that of ethanol and propanol oxidation and approximately 2-fold higher than for 
that of hexanol and cyclohexanol oxidation [Table 8; Figure 11-A].  The Vmax/Km value 
for trans-2-hexen-1-ol oxidation was 15 to 33-fold higher than the catalytic efficiencies 
for primary alcohols and over 1900-fold higher than the catalytic efficiencies for 
cyclohexanol oxidation [Table 9]. 
 When trans-2-hexen-1-ol was used as a substrate for the 22B isoenzyme, the Km 
value was lower compared to all primary alcohols (between 9-fold and 260-fold lower) 
and 60-fold lower than the Km for cyclohexanol [Table 7].  Similar to the behavior of the 
other primate isoenzymes, the Vmax for trans-2-hexen-1-ol oxidation was higher than for 
any other substrate tested with increases 1.5-fold compared to all primary alcohols and 
about 1.8-fold compared to cyclohexanol [Table 8; Figure 11-B].  The Vmax/Km value for 
trans-2-hexen-1-ol was higher than the catalytic efficiencies for all other primary 
alcohols (between 15- and 400-fold higher) and about 100-fold higher than for 
cyclohexanol [Table 9]. 
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     2. Enzymes: Sigma 2-1 and Sigma 2-2 
 A. Ethanol, Propanol, Butanol, Pentanol, and Hexanol as Substrates 
 Kinetic constants for both of the resurrected primate ADH isoforms, Sigma 2-1 
and Sigma 2-2, demonstrated similar trends in values for Km, Vmax, and Vmax/Km 
(catalytic efficiency) amongst primary aliphatic alcohols.  The Sigma 2-1 isoenzyme 
exhibited Km values that varied in a chain-length dependent manner—increasing 1.3-fold 
from ethanol to propanol, then decreasing 92-fold from propanol to hexanol [Table 10].  
In contrast, Vmax values increased as chain-length increased; demonstrating a 3.1-fold 
increase from ethanol to pentanol, and a 1.4-fold decrease from pentanol to hexanol 
[Table 11; Figure 12].  Catalytic efficiencies amongst primary aliphatic alcohols 
increased with increasing chain-length as well; where the Vmax/Km for ethanol and 
propanol were relatively constant, differing by a mere 1.3-fold, followed by a 130-fold 
increase from propanol to hexanol [Table 12].   
 Similar to Sigma 2-1, the Sigma 2-2 isoenzyme displayed Km, Vmax, and Vmax/Km 
values (catalytic efficiencies) that varied in a chain-length dependent manner.  Sigma 2-2 
also exhibited Km values which increased slightly from ethanol to propanol (1.2-fold), 
then decreased with increasing chain length from propanol to hexanol (170-fold) [Table 
10].  Contrary to Sigma 2-1, Sigma 2-2 exhibited Vmax values which continuously 
increased from ethanol to hexanol, displaying a 4-fold increase from ethanol to hexanol 
[Table 11; Figure 13].  Much like Sigma 2-1, catalytic efficiencies for isoenzyme Sigma 
2-2 remained constant from ethanol and propanol then increased with increasing chain 
length from propanol to hexanol (590-fold increase) [Table 12].   
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 B. Trans-2-hexen-1-ol as a Substrate 
 For both resurrected primate isoenzymes (Sigma 2-1 and Sigma 2-2) the 
unsaturated primary alcohol, trans-2-hexen-1-ol, was the best substrate.  For Sigma 2-1, 
the Km was lowest for trans-2-hexen-1-ol—demonstrating a 710-fold decrease compared 
to that for propanol, and a 7.7-fold decrease compared to that for hexanol [Table 10].  
The Vmax for trans-2-hexen-1-ol was also higher than all primary aliphatic alcohols 
tested; exhibiting a 7-fold increase compared to that for pentanol, and a 22-fold increase 
compared to that for ethanol [Table 11; Figure 11-C].  As expected, given the low Km and 
high Vmax values obtained, the catalytic efficiency for trans-2-hexen-1-ol increased 77-
fold compared to that for hexanol, and increased 12,000-fold compared to that for ethanol 
[Table 12].  
 For Sigma 2-2, Km values were lowest for trans-2-hexen-1-ol—demonstrating a 
1100-fold decrease compared to that for propanol, and a 6.5-fold decrease compared to 
that for hexanol [Table 10].  Likewise, the Vmax for trans-2-hexen-1-ol was higher than all 
primary aliphatic alcohols tested; exhibiting a 5.4-fold increase compared to that for 
pentanol, and a 22-fold increase compared to that for ethanol [Table 11; Figure 11-D].  
The catalytic efficiency for trans-2-hexen-1-ol exhibited a 33-fold increase compared to 
that for hexanol, and a 20,000-fold increase compared to that for ethanol [Table 12]. 
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Table 7: Km Constants (mM) of ADH Isoenzymes from Brown Lemur1 and 
Marmoset2 at pH 7.5 
 
 
 
 
Table 8: Vmax Constants (min-1) of ADH Isoenzymes from Brown Lemur1 and 
Marmoset2 at pH 7.5 
 
 
 
 
Table 9: Vmax/Km values (min-1mM-1) of ADH Isoenzymes from Brown Lemur1 and 
Marmoset2 at pH 7.5 
 
 
 
(All data was rounded to 2 significant figures.) 
 
2. 2M and 10M (unpublished) data was obtained from Hina Younus (previous graduate student) 
Ethanol 0.55 +/- 0.08 9.5 +/- 1.0 0.79 +/- 0.10 0.73 +/- 0.05
Propanol 0.64 +/- 0.09 1.1 +/- 0.1 0.95 +/- 0.12 0.39 +/- 0.05
Butanol 1.1 +/- 0.1 0.84 +/- 0.14 1.2 +/- 0.4 0.10 +/- 0.02
Pentanol 0.74 +/- 0.03 0.82 +/-0.14 0.61 +/- 0.09 0.07 +/- 0.01
Hexanol 0.47 +/- 0.03 0.32 +/- 0.07 0.81 +/- 0.21 0.06 +/- 0.01
Trans -2-hexen-1-ol 0.038 +/- 0.003 0.037 +/- 0.003 0.10 +/- 0.04 0.06 +/- 0.02
Cyclohexanol 40 +/- 14 2.2 +/- 0.6 2.1 +/- 0.13 0.06 +/- 0.00
SU
B
ST
R
A
T
E
S
Primate ADH 
isoenzymes → 4B
1 22B1 2M2 10M2
Ethanol 17 +/- 1 12 +/- 1 23 +/- 1 22 +/- 1
Propanol 18 +/- 2 12 +/- 1 22 +/- 1 15 +/- 1
Butanol 15 +/- 1 12 +/- 1 29 +/- 6 9 +/- 1
Pentanol 12 +/- 1 12 +/- 1 16 +/- 1 8 +/- 1
Hexanol 9.8 +/- 0.2 10 +/- 1 17 +/- 2 6 +/- 1
Trans -2-hexen-1-ol 18 +/- 1 18 +/- 1 35 +/- 10 28 +/- 6
Cyclohexanol 9.7 +/- 1.9 9.8 +/- 0.8 12 +/- 1 20 +/- 1
SU
B
ST
R
A
T
E
S
Primate ADH 
isoenzymes → 4B
1 22B1 2M2 10M2
Ethanol 30 1.2 29 30
Propanol 29 10 23 38
Butanol 14 15 24 90
Pentanol 17 15 26 110
Hexanol 21 32 21 100
Trans -2-hexen-1-ol 460 480 350 470
Cyclohexanol 0.24 4.5 6 330
SU
B
ST
R
A
T
E
S
Primate ADH 
isoenzymes → 4B
1 22B1 2M2 10M2
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Table 10: Km Constants (mM) of Ancestral1 and Human2 ADH Isoenzymes at pH 
7.5 
 
 
 
 
Table 11: Vmax Constants (min-1) of Ancestral1 and Human2 ADH Isoenzymes at     
pH 7.5 
 
 
 
 
Table 12: Vmax/Km Values (min-1mM-1) of Ancestral1 and Human2 ADH Isoenzymes 
at pH 7.5 
 
 
 
(All data was rounded to 2 significant figures.) 
 
2. Data from (Kedishvili et al. 1995) 
Ethanol 360 +/- 71 310 +/- 73 28
Propanol 470 +/- 200 370 +/- 13 1.4
Butanol 86 +/- 7 31 +/- 9 0.79
Pentanol 14 +/- 1 8.3 +/- 0.8 0.28
Hexanol 5.1 +/- 1.7 2.2 +/- 0.6 0.13
Trans -2-hexen-1-ol 0.66 +/- 0.04 0.34 +/- 0.02 0.019 S
U
B
ST
R
A
T
E
S
σσ2Sigma 2-21Sigma 2-11
ADH           
isoenzymes →
Ethanol 180 +/- 32 250 +/- 37 1,800
Propanol 300 +/- 54 310 +/- 13 1,000
Butanol 360 +/- 10 420 +/- 38 2,100
Pentanol 560 +/- 21 530 +/- 9 960
Hexanol 390 +/- 48 1,000 +/- 64 1,200
Trans -2-hexen-1-ol 3,900 +/- 64 5,400 +/- 64 2,200S
U
B
ST
R
A
T
E
S
Sigma 2-11 Sigma 2-21 σσ2
ADH           
isoenzymes →
Ethanol 0.49 0.82 65
Propanol 0.64 0.82 570
Butanol 4.2 13 2,600
Pentanol 39 64 3,400
Hexanol 78 480 9,000
Trans -2-hexen-1-ol 6,000 16,000 120,000
σσ2
ADH           
isoenzymes → Sigma 2-1
1 Sigma 2-21
SU
B
ST
R
A
T
E
S
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Figure 8: Michaelis-Menten Representative Graphs of 4B-ADH from Brown Lemur 
with Various Aliphatic Alcohols1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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Figure 9: Michaelis-Menten Representative Graphs of 22B-ADH from Brown 
Lemur with Various Aliphatic Alcohols1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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Figure 10: Michaelis-Menten Representative Graphs of Brown Lemur ADHs with 
Cyclohexanol1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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Figure 11: Michaelis-Menten Representative Graphs of Primate and Ancestral 
ADHs with Trans-2-hexen-1-ol as a Substrate.1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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Figure 12: Michaelis-Menten Representative Graphs of Ancestral, Sigma 2-1 ADH 
with Various Aliphatic Alcohols.1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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Figure 13: Michaelis-Menten Representative Graphs of Ancestral, Sigma 2-2 ADH 
with Various Aliphatic Alcohols.1 
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1. Data points represent the average of triplicate measurements recorded +/- standard error—which is 
represented by a vertical line through each data point. 
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IV. DISCUSSION 
     1. Background/ Review of ADH Genes and Isoenzymes 
 Alcohol dehydrogenase, encoded by the ADH gene family, is an enzyme that 
metabolizes various substrates: including ethanol, retinol, other aliphatic alcohols, 
hydroxysteroids, and lipid peroxidation products (Duester et al. 1999).  ADH isoenzymes 
exist in four biological kingdoms: bacteria, yeast, plants, and animals (Branden et al. 
1975).  Human ADH isoenzymes are zinc-containing dimers consisting of two 40-kD 
subunits [Figure 1].  Each subunit, containing a structural zinc ion and a catalytic zinc 
ion, is folded into two domains: a coenzyme-binding domain and a catalytic domain.  
These domains are separated by a cleft containing a deep pocket—which accommodates 
the substrate and the nicotinamide moiety of the coenzyme.  Homologous interactions 
within the coenzyme binding domains of each subunit link the dimers together (Eklund et 
al. 1976). 
 Seven alcohol dehydrogenase (ADH) genes have been identified in humans—
ADH1A, ADH1B, ADH1C, ADH4, ADH5, ADH7, and ADH6 (Hurley et al. 2002).  This 
seven-gene cluster is found on chromosome four in humans (Edenberg 2000).  ADH 
isoenzymes are classified into individual classes based on function and sequence identity 
(Duester 1999; Edenberg 2000).  There is currently some disagreement amongst 
investigators and the Human Genome Organization (HUGO) concerning gene 
nomenclature assignments.  This thesis will utilize the HUGO assignments.  However the 
current literature can be confusing depending on which nomenclature is utilized (for 
review, see Duester 1999 and Hurley et al. 2002).  In humans, the Class I isoenzymes are 
encoded by genes ADH1A, ADH1B, and ADH1C—which yield the protein products α, β, 
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an γγ, respectively.  Polymorphisms occur at the ADH1B and ADH1C loci with different 
distributions amongst racial populations, giving rise to the ADH1B*1, ADH1B*2, and 
ADH1B*3 alleles and the ADH1C*1 and ADH1C*2 alleles (Hurley et al. 2002).  Class II, 
encoded by human ADH4, yields the protein product π; Class III, encoded by human 
ADH5, yields χ; and Class IV, encoded by human ADH7 yields σ (Duester 1999).  The 
Class V isoenzyme, human ADH6 has only been identified at the gene and transcriptional 
level—and its function remains unknown (Hoog & Ostberg 2011). 
 On an evolutionary scale, human Class III and Class II ADHs probably diverged 
around 630 and 600 million years ago, respectively; while human Class IV appeared 520 
million years ago—implying that these classes of enzymes may exist or have existed in 
all vertebrates.  However, human Class I ADHs diverged 80 million years ago—before 
human, baboon, and monkey Class I ADHs—which is also when angiosperms first began 
to produce fleshy fruits whose sugars are fermented to ethanol by yeasts.  This supports 
the proposal that duplications of the primate Class I gene could have predated primate 
radiation.  Thus, human Class I ADH isoenzymes may exist or have existed in all 
primates (Sun & Plapp 1992).  
 It has been speculated that the highly conserved sequences on the three duplicated 
(Class I) ADH genes in primates have been achieved essentially by maintaining stability 
of the hetero-dimer formation that might have been related to dietary adaptation in 
primate evolution.  Or in other words, this implies that the evolution of Class I ADH 
genes is associated with dietary adaptations in the primate lineage (Oota et al. 2007).  
Tables 1, 2 and 3 can be analyzed to demonstrate that the duplication of Class I ADH to 
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yield three two or three unique isoenzymes results in a broader range of substrate 
oxidation capacity. 
The kinetic properties and amino acid substitutions within the substrate binding 
sites of primate ADH isoforms were examined in order to understand how ethanol 
oxidizing capability has been selected for during primate evolution.  Amino acid 
substitutions of the inner (positions 48 and 93), middle (141, 294, 309, and 318), and 
outer (57, 116, and 306) regions of the substrate binding pocket were compared and 
analyzed [Tables 13 & 14].  Ultimately, the different topologies of substrate binding 
pockets derived from amino acid substitutions were used to explain the substrate 
preferences of the individual ADH isoforms. 
     2. ADH Isoenzymes from Marmoset (2M & 10M) and Brown Lemur (4B & 22B) 
 When comparing kinetic properties among the four primate isoenzymes observed, 
it appears as though 4B and 2M displayed similar properties; whereas 22B and 10M 
displayed similar properties [Tables 7-9].  Both isoenzymes 4B and 2M exhibited highest 
Vmax/Km values for ethanol. The catalytic efficiencies change very little for propanol, 
butanol, pentanol, and hexanol.  Furthermore, both 4B and 2M display relatively higher 
Km values for cyclohexanol in comparison to 22B and 10M, respectively.  Both of these 
observations are likely due to the presence of threonine at position 48 in these 
isoenzymes [Figures 14-A & 15-A].  Like with human ββ, the additional methyl group in 
the threonine side chain interferes with the binding of alcohols with substitutes other than 
two hydrogens at the C1 position (Niederhut et al. 2001).  Thus, secondary alcohols are 
generally poor substrates for isoenzymes containing Thr-48 (Eklund et al. 1987). 
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The primate isoenzymes 22B and 10M both exhibit Vmax/Km values that increase 
with increasing substrate chain length.  Furthermore, 22B and 10M also both display 
lower Km values for cyclohexanol compared to 4B and 2M, respectively [Tables 7-9].  
These observations are probably due to the presence of serine at position 48 in these 
isoenzymes—which gives a larger space (compared to Thr-48) for bulkier substrates like 
cyclohexanol [Figures 14-B & 15-B] (Hoog et al. 1992).  This larger space can also 
explain the increasing catalytic efficiencies as the substrate chain length increases.  In 
essence, as the size of the substrate increases, the Vmax/Km value increases.  Thus, it 
appears as though the longer-chain substrates fill the substrate-binding pocket and 
interact more favorably with the enzyme (Light et al. 1992).  In conclusion, long-chain 
primary alcohols and secondary alcohols like cyclohexanol are fairly good substrates for 
ADH isoenzymes containing Ser-48—as observed with human γγ. 
Although the most substantial changes in substrate specificity result from amino 
acid substitutions within the inner region of the substrate-binding site (residues 48 and 
93), substitutions in the middle and outer regions can also effect substrate specificity 
(Niederhut et al. 2001). 
As previously stated, isoenzymes 4B and 2M display similar trends in kinetic 
properties; however, the Vmax/Km value for cyclohexanol is 25-fold higher for 2M 
compared to 4B [Table 9].  In order to determine where this difference in substrate 
preference arises, a good starting point would be to determine where 4B and 2M differ in 
amino acid at positions within the substrate binding site.  These isoenzymes differ at 
residues 318, 57, and 306—where 4B contains Val-318, Met-57, and Leu-306, and 2M 
contains Leu-318, Leu-57, and Met-306.  It can be observed that Leu-318 in 2M is 
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positioned to yield more room in the substrate binding site than the corresponding Val-
318 present in 4B.  In addition to this observation, the presence of Leu-57 in 2M also 
gives more space compared to the larger Met-57 present in 4B [Figures 16-A & 16-B].  
The additional space created in 2M at positions 318 and 57 probably explains why 
cyclohexanol is a better substrate for 2M compared to 4B.   
Although the isoenzymes 22B and 10M displayed similar kinetic trends, 
noticeable differences between the two isoenzymes are: (1) the Vmax/Km value for ethanol 
is 25-fold higher for 10M compared to 22B, and (2) the Vmax/Km value for cyclohexanol 
is 73-fold higher for 10M compared to 22B [Table 9].  These two isoenzymes differ at 
four residues within the substrate-binding site—141, 57, 116, and 306.  It can be 
observed that 22B contains Ala-141 in the middle region of the substrate binding site, 
while 10M contains Leu-141.  The substitution of Leu→Ala-141 generates more space; 
which may explain why 10M has a 25-fold higher Vmax/Km value for ethanol compared to 
22B [Figures 17-A & 17-B].  In addition to position 141, 22B and 10M differ at three 
positions within the outer region of the substrate binding site—57, 116, and 306.  While 
22B contains Ile-57, Val-116, and Leu-306, 10M contains Leu-57, Leu-116, and Met-
306.  The three outer amino acids present in 22B are smaller than all of the amino acids 
present in 10M (in respective positions).  These smaller groups present in 22B yield a 
larger substrate binding site [Figures 18-A & 18-B].  It is possible that cyclohexanol is a 
worse substrate for 22B compared to 10M due to the fact that the substrate binding site is 
too big; thus, cyclohexanol doesn’t interact with the isoenzyme as well.   
It can be observed that all four primate isoenzymes exhibited the lowest Km 
values and the highest Vmax/Km values with trans-2-hexen-1-ol as a substrate [Tables 7-
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9].  This phenomena is probably due to the fact that trans-2-hexen-1-ol resembles the 
alcohol end of retinol—which is an established substrate in vivo for alcohol 
dehydrogenases (Julia et al. 1986).  The competitive oxidation of ethanol over retinol by 
alcohol dehydrogenase has been proposed to interfere with retinoic acid synthesis—
which can cause fetal alcohol syndrome, or FAS (Duester 1991; Pullarkat 1991).  
                     
         trans-2-hexen-1-ol 
 
                         Retinol 
 The kinetic data obtained from each primate’s pair of isoenzymes can be used to 
predict which species would be better-suited for ethanol oxidation [Tables 7-9].  Since 
the average Vmax/Km value with ethanol for the two isoenzymes from marmoset (29.5 
min-1 mM -1) is higher than the average calculated from the brown lemur isoenzymes 
(15.6 min-1mM -1), marmoset would appear to have a better capacity for ethanol 
oxidation.  This observation supports the suggestion that ethanol oxidation occurred late 
in primate evolution since lemurs and humans diverged from a common ancestor 62-65 
million years ago, while humans and marmosets diverged 35-40 million years ago (Yoder 
& Yang 2004; Cronin & Sarich 1978). 
     3. Ancestral ADH Isoenzymes (Sigma 2-1 & Sigma 2-2) 
 Kinetic properties and amino acid substitutions within the substrate binding sites 
of the ancestral ADH isoforms, Sigma 2-1 and Sigma 2-2, were also examined and 
compared to human σσ-ADH [Tables 10-12; Table 14]. 
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 Both ancestral ADH isoforms exhibit catalytic efficiencies that increase with 
increasing substrate chain length, as well as Km values that decrease with increasing 
chain length.  Both of these trends are also demonstrated in human σσ; however, Km 
values are several-fold lower and Vmax/Km values are several-fold higher for σσ compared 
to Sigma 2-1 and Sigma 2-2.  These observations are likely a result of the amino acid 
substitution at position 294—where σσ contains Val-294, and both ancestral isoforms 
contain Ala-294 (which is also present in the rat class IV ADH isoenzyme).  The 
exchange of valine to alanine in the middle region of the substrate binding pocket results 
in extra space at the active site…which explains why Sigma 2-1 and Sigma 2-2 have such 
a low affinity for small substrates like ethanol [Figures 4-A, 4-B, & 4-C] (Farres et al. 
1994).  This is demonstrated in Table 10, where Sigma 2-1 and Sigma 2-2 display 
approximate 12-fold increases in Km values for ethanol compared to σσ. 
 The change from Ala-294 to Val-294 in primate ADH evolution suggests that a 
major adaptation to ethanol occurred very recently—based on the drastic shift in Km for 
ethanol [Table 10].  It is estimated that this single A294V change occurred between node 
34 and modern human about 15 million years ago [Figure 6]; due to the fact that human, 
chimp, and gorilla all have this A294V change, but orangutan does not (Carrigan 2011).  
 Although Sigma 2-1 and Sigma 2-2 display very similar kinetic trends, Sigma 2-2 
demonstrates an approximate 2-fold decrease in Km values for substrates longer than 
propanol, and demonstrates higher catalytic efficiencies for all substrates; ranging from 
1.3-fold to 6-fold increases [Tables 10-12].  These differences probably arise from the 
amino acid substitution of Val-116 for Ile-116 in Sigma 2-2 [Table 14].  Since the 
isoleucine residue is larger than valine, it provides a better contact surface for longer 
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chain alcohol substrates which explains the lower Km values of Sigma 2-2 with butanol, 
pentanol, and hexanol [Figures 4-B & 4-C] (Hoog et al. 1992).   
 Similar to the primate isoenzymes, Sigma 2-1 and Sigma 2-2 displayed lowest Km 
values and highest Vmax/Km values with trans-2-hexen-1-ol as a substrate [Tables 10-12].  
Furthermore, Sigma 2-1 demonstrated catalytic efficiencies that were 13-17-fold higher 
than the primate isoenzymes with trans-2-hexen-1-ol, and Sigma 2-2 exhibited values 
that were 33-46-fold higher than primate isoenzymes.  This observation correlates to the 
finding that human σσ isoenzymes are more efficient at oxidizing retinol than any other 
human isoenzyme (Yang et al. 1994). 
     4. Summary of Findings 
 The kinetic data obtained from the primate Class I ADH experiments indicates 
that the common marmoset has a higher catalytic efficiency towards ethanol oxidation 
than the brown lemur—due to the fact that the average catalytic efficiency calculated for 
the two isoforms from marmoset was approximately 2-fold higher than the average 
calculated for the two isoforms from brown lemur.  This finding supports the hypothesis 
that the species with the higher content of fermentable fruit in its diet has a higher 
catalytic efficiency towards ethanol oxidation—since marmosets display a preference for 
fruit when it is available, while brown lemurs have access to fruits year-round but are 
classified as opportunistic foragers.  
 The kinetic data obtained from the human ancestral Class IV ADH experiments 
indicates that the single A294V change, which occurred approximately 15 million years 
ago in primate evolution, increased the catalytic efficiency of this isoenzyme towards 
ethanol oxidation by approximately 80-fold.  This finding supports the hypothesis that the 
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ability of Class IV ADH to efficiently oxidize ethanol developed late in primate evolution 
and results primarily from the singe A294V change.  A likely explanation for this change 
is that a higher catalytic efficiency toward ethanol in the Class IV ADH isoenzyme 
permits greater ethanol oxidizing capacity during first-pass metabolism and thus allows 
the organism to handle greater dietary loads of ethanol without functional impairment.  
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Table 13: Amino Acids Present in the Substrate Site of ADHs from Marmoset and 
Brown Lemur 
 
 
 
 
 
 
 
Table 14: Amino Acids Present in the Substrate Site of Ancestral ADHs and Human 
σσ-ADH 
 
 
 
  
REGION Position
αα ββ γγ 4B 22B 2M 10M
48 Thr Thr Ser Thr Ser Thr Ser
93 Ala Phe Phe Phe Phe Phe Phe
141 Leu Leu Val Leu Ala Leu Leu
294 Val Val Val Val Val Val Val
309 Leu Leu Leu Leu Leu Leu Leu
318 Ile Val Ile Val Val Leu Val
57 Met Leu Leu Met Ile Leu Leu
116 Val Leu Leu Leu Val Leu Leu
306 Met Met Met Leu Leu Met Met
Human Class I Marmaset
INNER
MIDDLE
OUTER
Brown Lemur
REGION Position Human 
Class IV
σσ Sigma2-1 Sigma2-2
48 Thr Thr Ser
93 Phe Phe Phe
141 Met Met Met
294 Val Ala Ala
309 Phe Phe Phe
318 Val Val Val
57 Met Met Met
116 Ile Val Ile
306 Met Met Met
INNER
MIDDLE
OUTER
Human Ancestral
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Figure 4: Comparison of Substrate Sites from Ancestral ADH isoenzymes with 
Human σσ-ADH 
A. Human σσ-ADH Substrate Site 
 
B. Ancestral, Sigma 2-1 ADH Substrate Site 
 
Figure 4-A 
 
-Human σσ-ADH substrate 
site displaying Thr-48 in 
the Inner Region, and Met-
141, Val-294, and Phe-309 
in the Middle Region of the 
substrate binding site.  
-Generated with PyMOL.  
Figure 4-B 
 
-Sigma 2-1 ADH substrate 
site displaying Thr-48 in 
the Inner Region, and Met-
141, Ala-294, and Phe-309 
in the Middle Region of the 
substrate binding site. 
-The Val→Ala substitution 
at position 294 creates extra 
space at the active site.   
-Generated with PyMOL.  
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Figure 4: Comparison of Substrate Sites from Ancestral ADH Isoenzymes with 
Human σσ-ADH (continued) 
C. Ancestral, Sigma 2-2 ADH Substrate Site 
 
  
Figure 4-C 
 
-Sigma 2-2 ADH substrate 
site displaying Ser-48 in 
the Inner Region, and Met-
141, Ala-294, and Phe-309 
in the Middle Region of the 
substrate binding site. 
-The Thr→Ser substitution 
at position 48 creates extra 
space at the active site 
when compared to that of 
Sigma 2-1.    
-Generated with PyMOL.  
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Figure 14: Comparison of Position 48 in the Substrate Sites of4B and 22B from 
Brown Lemur 
A. 4B-ADH Substrate Site Displaying Position 48 
 
B. 22B-ADH Substrate Site Displaying Position 48  
 
Figure 14-A 
 
-4B-ADH substrate site 
displaying Thr-48 in the 
Inner Region, in addition 
to Phe-140 and Leu-141 in 
the Middle Region of the 
substrate binding site. 
-Generated with PyMOL.  
 
Figure 14-B 
 
-22B-ADH substrate site 
displaying Ser-48 in the 
Inner Region, in addition to 
Phe-140 and Ala-141 in the 
Middle Region of the 
substrate binding site. 
-The Thr→Ser substitution 
at position 48 creates extra 
space at the active site in 
comparison to 4B.  
-Generated with PyMOL.  
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Figure 15: Comparison of Position 48 in the Substrate Sites of 2M and 10M from 
Marmoset 
A. 2M-ADH Substrate Site Displaying Position 48 
 
B. 10M-ADH Substrate Site Displaying Position 48 
 
Figure 15-A 
 
-2M-ADH substrate site 
displaying Thr-48 in the 
Inner Region, as well as 
Phe-140 and Leu-141 in the 
Middle Region of the 
substrate binding site. 
-Generated with PyMOL.  
 
Figure 15-B 
 
-10M-ADH substrate site 
displaying Ser-48 in the 
Inner Region, in addition to 
Phe-140 and Leu-141 in the 
Middle Region of the 
substrate binding site. 
-The Thr→Ser substitution 
at position 48 creates extra 
space at the active site in 
comparison to 2M.  
-Generated with PyMOL.  
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Figure 16: Comparison of Substrate Sites of 4B from Brown Lemur and 2M from 
Marmoset 
A. 4B-ADH Substrate Site 
 
B. 2M-ADH Substrate Site  
 
Figure 16-A 
 
-4B-ADH substrate site 
displaying Leu-309 and 
Val-318 in the Middle 
Region, as well as Leu-116 
and Leu-306 in the Outer 
Region of the substrate 
binding site.  
-Generated with PyMOL.  
Figure 16-B 
 
-2M-ADH substrate site 
displaying Leu-309 and Leu-
318 in the Middle Region, as 
well as Leu-116 and Met-306 
in the Outer Region of the 
substrate binding site.  
-Both exchanges, Val→Leu 
at position 318 and Met-Leu 
at position 57, result in extra 
space in the substrate site.    
-Generated with PyMOL.  
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Figure 17: Comparison of Position 141 in the substrate sites of 22B from Brown 
Lemur and 10M from Marmoset 
A. 22B-ADH Substrate Site 
 
B. 10M-ADH Substrate Site 
 
Figure 17-A 
 
-22B-ADH substrate site 
displaying Ala-141 in the 
Middle Region, of the 
substrate binding site.  
-Generated with PyMOL.  
 
Figure 17-B 
 
-10M-ADH substrate site 
displaying Leu-141 in the 
Middle Region, of the 
substrate binding site.  
-The Ala→Leu substitution 
at position 141 leaves less 
space in the substrate 
binding site compared to 
22B. 
-Generated with PyMOL.  
 
63 
 
Figure 18: Comparison of Positions 57 and 116 in the Substrate Sites of 22B from 
Brown Lemur and 10M from Marmoset 
A. 22B-ADH Substrate Site 
 
B. 10M-ADH Substrate Site 
 
Figure 18-A 
 
-22B-ADH substrate site 
displaying Ile-57 and Val-
116 in the Outer Region 
of the substrate binding 
site.  
-Generated with PyMOL.  
 
Figure 18-B 
 
-10M-ADH substrate site 
displaying Leu-57 and Leu-
116 in the Outer Region of 
the substrate binding site. 
-Both, the Ile→Leu 
substitution at position 57 
and the Val→Leu 
substitution at position yield 
less room in the substrate 
binding site compared to 
22B.   
-Generated with PyMOL.  
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V. CONCLUSIONS 
 Data obtained from experiments with both, Class I and Class IV ADH isoenzymes 
supports the proposal that recent events occurred during primate evolution that increased 
the capacity to efficiently oxidize ethanol.  Two main conclusions can be drawn with 
respect to the evolution of ethanol metabolism in primates: (1) multiple Class I ADH 
duplication events occurred during primate evolution which resulted in a broader 
substrate-oxidizing capacity.  This discovery supports the suggestion that primate Class I 
ADH evolution is associated with dietary adaptations in the primate lineage.  (2) A 
separate event, consisting of a single amino acid exchange, occurred 15 million years ago 
which resulted in a 79-fold increase in the ethanol-oxidizing capability of Class IV ADH 
isoenzymes. 
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